MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute myeloid leukemia cells
Abstract:
Acute myeloid leukemia (AML) has a 5-year survival rate of only about 30%-40% due to the self-renewal and differentiation ability of leukemia stem-like cells (LSCs). To address the potential for novel therapeutic targets in LSCs, we investigated the roles of miRNA-126 and tumor necrosis factor receptor-associated factor 7 (TRAF7) in AML. We used qRT-PCR and Western blot to investigate the expression levels of miRNA-126 and TRAF7 in AML cell lines. Then, we uncovered the effect of miRNA-126 on AML cell proliferation and apoptosis by MTT assay and flow cytometric analysis, respectively. Furthermore, dual-luciferase assay and Western blot were used to determine the target of miRNA-126 in AML and the potential mechanism by which cell apoptosis is suppressed by miRNA-126. We found that miRNA-126 was highly expressed in all of the AML cell lines, and that inhibition of miRNA-126 significantly induced cell death through apoptosis. The suppression of apoptosis in AML with high expression of miRNA-126 was caused by down-regulating TRAF7, which blocked the c-FLIP pathway. The role of miRNA-126 in AML makes it a potential therapeutic target to improve clinical outcomes for patients with AML.
Insights
MicroRNA-126 (miRNA-126) promotes acute myeloid leukemia (AML) survival by down-regulating TRAF7, inhibiting apoptosis. Inhibiting miRNA-126 offers a potential therapeutic strategy for AML patients.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Acute myeloid leukemia (AML) exhibits poor prognosis, largely due to leukemia stem-like cells (LSCs) with self-renewal and differentiation capabilities.
- Identifying novel therapeutic targets within LSCs is crucial for improving AML patient outcomes.
Purpose of the Study:
- To investigate the roles of microRNA-126 (miRNA-126) and tumor necrosis factor receptor-associated factor 7 (TRAF7) in AML.
- To elucidate the mechanism by which miRNA-126 influences AML cell proliferation and apoptosis.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot to assess miRNA-126 and TRAF7 expression.
- MTT assay for cell proliferation and flow cytometry for apoptosis analysis.
- Dual-luciferase assay to identify miRNA-126 targets and confirm the TRAF7-mediated apoptosis suppression pathway.
Main Results:
- miRNA-126 was highly expressed across all investigated AML cell lines.
- Inhibition of miRNA-126 significantly induced apoptosis and cell death in AML cells.
- High miRNA-126 expression suppresses apoptosis by down-regulating TRAF7, which subsequently blocks the c-FLIP pathway.
Conclusions:
- miRNA-126 plays a significant role in AML pathogenesis by promoting cell survival.
- Targeting miRNA-126 presents a promising therapeutic strategy to enhance apoptosis and improve clinical outcomes in AML.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
10:02Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
Related Concept Videos
MicroRNAs
MicroRNAs
Differentiation of Common Myeloid Progenitor Cells
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Apoptosis
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
